H47.233
Glaucomatous optic atrophy, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Bilateral glaucomatous optic atrophy is a progressive eye condition characterized by damage to the optic nerves in both eyes due to glaucoma. The optic nerve is responsible for transmitting visual information from the eye to the brain. When it becomes atrophied or damaged, it can lead to vision loss or even blindness if not properly managed. This condition is typically associated with increased intraocular pressure from glaucoma, which puts strain on the optic nerves over time.
Causes & Symptoms
Clinical Causes: Elevated intraocular pressure (ocular hypertension) Chronic open-angle glaucoma Angle-closure glaucoma (less common in bilateral cases but still possible) Secondary glaucoma resulting from eye injuries or inflammation Genetic predisposition to glaucoma Age-related changes in eye tissue Certain medical conditions like diabetes or hypertension
Key Symptoms: Gradual loss of peripheral (side) vision Difficulty adapting to darkness or low light Blurred or hazy vision Occasional eye pain or headache (less common in early stages) In severe cases, central vision may become affected, leading to difficulty reading or recognizing faces Absence of noticeable symptoms in early stages, highlighting the need for regular eye examinations
Diagnostic & Treatment
Diagnosis Path: Diagnosis of bilateral glaucomatous optic atrophy involves a comprehensive eye examination including:
Treatment Protocols: While there is no cure for glaucomatous optic atrophy, treatment aims to slow progression and prevent further vision loss. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H47.233 a billable ICD-10 code?
Yes, H47.233 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H47.233?
Clinical documentation must specify the nature of Glaucomatous optic atrophy, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
